| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/20/2000 | WO1999064050A9 Novel potassium channel drugs and their uses |
| 04/20/2000 | WO1999008691A8 Use of locally delivered metal ions for treatment of periodontal disease |
| 04/20/2000 | DE19847969A1 Stable liquid formulation of formoterol in solution or suspension medium, used after dilution for treatment of asthma by inhalation |
| 04/20/2000 | DE19847968A1 Separate storage of an active material and a solvent comprises a closure cap and a container, with a chamber attached to the unit. |
| 04/20/2000 | DE19847715A1 Treatment of schizophrenia symptoms without side effects, by transdermal administration of nicotine or its salt |
| 04/20/2000 | DE19847618A1 Production of solid dosage forms, used for e.g. pharmaceuticals or insecticides, by preparation of plastic mixture from polymeric binder and active agent under controlled conditions |
| 04/20/2000 | DE19847593A1 Parenteral drug administration composition with depot and controlled release comprises active agent and water soluble polysaccharide microparticles as carrier |
| 04/20/2000 | DE19845278A1 Retard tablet of antiepileptic agent losigamone, containing combination of retarding and disintegrating agents to provide appropriate slow release from tablet of acceptable size |
| 04/20/2000 | CA2346867A1 Use of ophthalmic composition comprising vitamin a and vitamin e |
| 04/20/2000 | CA2346670A1 Composition for the parenteral administration of active compounds |
| 04/20/2000 | CA2346464A1 Peripherally acting anti-pruritic opiates |
| 04/20/2000 | CA2346307A1 Formulations of fexofenadine |
| 04/20/2000 | CA2345458A1 Novel ultrasound contrast agents |
| 04/20/2000 | CA2315375A1 A dried or frozen pharmaceutical preparation containing a class iii antiarrhythmic compound |
| 04/20/2000 | CA2312032A1 Stable oil-in-water emulsion, method for preparing same and use in cosmetics and dermatology |
| 04/19/2000 | EP0993834A1 Adsorbents for toxic shock syndrome toxin-1, method for eliminating the toxin by adsorption, adsorbers packed with the adsorbents, and use of the adsorbents |
| 04/19/2000 | EP0993831A2 Compounds and compositions for delivering active agents |
| 04/19/2000 | EP0993830A2 New stabilized galenic formulations comprising an acid labile benzimidazole compound and its preparation |
| 04/19/2000 | EP0993829A1 Transdermal preparation containing serotonin receptor antagonist |
| 04/19/2000 | EP0993828A1 Method of producing coated solid dosage forms |
| 04/19/2000 | EP0993827A1 Aerosols |
| 04/19/2000 | EP0993484A1 Particulate polymeric materials and their production |
| 04/19/2000 | EP0993483A1 Conjugate of polyethylene glycol and chitosan |
| 04/19/2000 | EP0993337A1 Hydrophilic polymeric material and method of preparation |
| 04/19/2000 | EP0993314A1 Syringe and capsule therefor |
| 04/19/2000 | EP0993297A1 Dilating and support apparatus with disease inhibitors and methods for use |
| 04/19/2000 | EP0973605A4 Heat resistant lipid vesicles |
| 04/19/2000 | EP0813396A4 Controlled dissolution pellet containing calcium sulfate |
| 04/19/2000 | EP0741565B1 Process for producing s(+)-ibuprofen particles |
| 04/19/2000 | EP0668769B1 Synthetic compositions related to oak bark extrakt, and method of using same |
| 04/19/2000 | EP0665741B1 Topical ophthalmic pharmaceutical vehicles |
| 04/19/2000 | EP0652775B1 Targeting of liposomes to the blood-brain barrier |
| 04/19/2000 | CN1251075A Multi-compartment rehydrating container |
| 04/19/2000 | CN1251045A Gel delivery vehicles for anticellular proliferative agent |
| 04/19/2000 | CN1251036A Implantable delivery device with self adjustable exit port |
| 04/19/2000 | CN1251035A Gastrointestinal mucosa-adherent pharmaceutical composition |
| 04/19/2000 | CN1251033A Anti-viral, anhydrous and mild skin lotions for application to tissue paper products |
| 04/19/2000 | CN1250669A Ion composite type water-soluble pharmaceutical compositions, and use thereof |
| 04/19/2000 | CN1250668A Stable protein compositions |
| 04/19/2000 | CN1250660A Liquid medicine for treating wound and pain |
| 04/19/2000 | CN1250658A Desensitizing chewing gum containing tea extract and is preparing process |
| 04/19/2000 | CN1250657A Multi-stage mixing process for decouring raw liquid of Chinese medicine |
| 04/19/2000 | CN1250655A Method for making multifunctional health-care chewing gum |
| 04/19/2000 | CN1250650A Powder type stable vitamin and cartotenoid prepns., and method for producing same |
| 04/19/2000 | CN1250648A Cosmetics prepn. compositions |
| 04/19/2000 | CN1250608A Fluidizable and methionine contg. type shaped accessory food factor, and method for preparing same |
| 04/19/2000 | CN1051469C Traditional Chinese medicine capsule for treating habitual constipation |
| 04/19/2000 | CN1051460C Method for treatment of leukoderma and its preparing method |
| 04/19/2000 | CN1051457C Medicine for rheumatic arthritis and its prepn. method |
| 04/19/2000 | CN1051453C Compositions of clindamycin and benzoyl peroxide for acne treatment |
| 04/18/2000 | US6051686 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 04/18/2000 | US6051613 Nitrogen monoxide production suppressor |
| 04/18/2000 | US6051608 Solid compositions suitable for oral administration comprising L-carnitine or alkanoyl-L-carnitine magnesium fumarate |
| 04/18/2000 | US6051600 Lipid carrier taxane derivative-containing pharmaceutical compositions useful in treatement of cancers |
| 04/18/2000 | US6051594 Orally administering a formulation of the vasodilator phentolamine to the blood circulation |
| 04/18/2000 | US6051567 Stable aqueous solution |
| 04/18/2000 | US6051566 Anti-reactive anti-asthmatic activity of non-steroidal anti-inflammatory drugs by inhalation |
| 04/18/2000 | US6051561 Compounds and compositions for delivering active agents |
| 04/18/2000 | US6051558 Compositions suitable for controlled release of the hormone GnRH and its analogs |
| 04/18/2000 | US6051551 Antidiabetic agents; hypoglycemic agents; inhalationadministering |
| 04/18/2000 | US6051429 Peptide-enhanced cationic lipid transfections |
| 04/18/2000 | US6051410 Self-assembled, defective, nonself-propagating viral particles |
| 04/18/2000 | US6051259 Composition for sustained release of human growth hormone |
| 04/18/2000 | US6051258 Proteinoid emulsions and methods for preparation and use thereof |
| 04/18/2000 | US6051257 Aerosol is produced having a tightly controlled droplet size to produce pharmaceutically-active particles having a small particle size and narrow particle size distribution. |
| 04/18/2000 | US6051256 Dispersible macromolecule compositions and methods for their preparation and use |
| 04/18/2000 | US6051255 Polymer coated tablet comprising amoxycillin and clavulanate |
| 04/18/2000 | US6051254 Amoxycillin hydrate, an effervescent couple, beta.-lactamase inhibitor; the effervescent couple comprises an acid component and an alkaline component |
| 04/18/2000 | US6051253 Shaping takes place in two steps, with the extrudate being broken into shaped articles in a first step, and these shaped articles being rounded off in a second step in the plastic state. |
| 04/18/2000 | US6051252 Compacted ribavirin composition substantially free of other ribavirin polymorphic forms. |
| 04/18/2000 | US6051251 Liposome loading method using a boronic acid compound |
| 04/18/2000 | US6051250 Process for the stabilization of vesicles of amphiphilic lipid(s) and composition for topical application containing the said stabilized vesicles |
| 04/18/2000 | US6051248 Compliant tissue sealants |
| 04/18/2000 | US6051245 Water soluble polymer composition for use as thickeners/stabilizers for products for topical application such as personal care products for application to skin or hair, or topically administrable pharmaceutical preparations |
| 04/18/2000 | US6051244 Treating skin aging by topically applying to affected skin areas fructose 1,6-diphosphate or its salts or mixtures to inhibit loss of elastic and collagen fibers in the dermis |
| 04/18/2000 | US6051243 Polyaromatic amide compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 04/18/2000 | US6051238 Stabilizers for lyophilized mumps vaccines |
| 04/18/2000 | US6051223 Mixing with anionic polymer, acid, amine or their salts |
| 04/18/2000 | US6051211 Stable w/o photoprotective cosmetic emulsions |
| 04/18/2000 | US6050988 Device for enhancing transdermal agent flux |
| 04/18/2000 | CA2141026C Pharmaceutical compositions for transmucosal delivery of peptides |
| 04/18/2000 | CA2137297C Reactive vesicle and functional substance-fixed vesicle |
| 04/18/2000 | CA2124553C Pharmaceutical tablet capable of releasing the active ingredients contained therein at subsequent times |
| 04/18/2000 | CA2069485C Delayed release formulations |
| 04/18/2000 | CA2009570C Electrotransport adhesive |
| 04/13/2000 | WO2000061108A1 Pharmaceutical aerosol formulation |
| 04/13/2000 | WO2000020609A2 Protective recombinant haemophilus influenzae high molecular weight proteins |
| 04/13/2000 | WO2000020602A2 Delta 6 and delta 12 desaturases and modified fatty acid biosynthesis and products produced therefrom |
| 04/13/2000 | WO2000020458A1 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage |
| 04/13/2000 | WO2000020432A1 Antisense modulation of bcl-x expression |
| 04/13/2000 | WO2000020395A1 New crystal modification iii of torasemide |
| 04/13/2000 | WO2000020036A1 Pharmaceutical compositions containing paclitaxel |
| 04/13/2000 | WO2000020035A1 Oxybutynin formulations and methods of use |
| 04/13/2000 | WO2000020033A1 Tablets immediately disintegrating in the oral cavity |
| 04/13/2000 | WO2000020017A2 Controlled-release garlic formulations |
| 04/13/2000 | WO2000020012A1 Agent called 'astromelanin'/'astronella' for treating pathological conditions |
| 04/13/2000 | WO2000020000A1 Controlled release oral preparations of esculetin and its derivatives |
| 04/13/2000 | WO2000019996A1 Controlled drug release system of retinoic acid |
| 04/13/2000 | WO2000019987A1 Mucosal originated drug delivery systems and animal applications |
| 04/13/2000 | WO2000019986A1 Tape material for transcutaneous absorption |